This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

News
11 Aug 2011

GNS Healthcare with BMS to Identify Biomarkers in Immuno-inflammation

GNS will use clinical and molecular information from a Bristol-Myers Squibb clinical trial to build computer models to identify key molecular mechanisms.

Healthcare analytics company GNS Healthcare, Inc. announced Wednesday it has formed a partnership with Bristol-Myers Squibb Company for the discovery of novel disease biology and biomarkers in the area of immuno-inflammation.

 

Utilizing its supercomputer-driven REFS (reverse-engineering and forward-simulation) platform, GNS will use clinical and molecular information from a Bristol-Myers Squibb clinical trial to build computer models in a hypothesis-free, unbiased manner that will be simulated to identify key molecular mechanisms.

 

Using patient data comprised of genetic information, gene expression levels, specific blood markers and clinical outcomes researchers will use REFS to construct a comprehensive inflammation disease mo

Related News